| Xiromed SA - Sitagliptin Xiromed 25 mg, Filmtabletten | | 68914 | | 01 | | Sitagliptin Xiromed 25 mg | | Filmtabletten | | A10BH01 | | Sitagliptin | | 17.10.2022 | | |
| | Composition | | sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: lactosum monohydricum 1.2 mg, hypromellosum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.675 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Sitagliptine | 25 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Rubrum) | | | | Calcium Hydrogen Phosphate | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 1.2 mg | Überzug | | Magnesii Stearas | | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 28 | PR | PR | B | | Yes | | 002 | 98 | PR | PR | B | | Yes | | 003 | 100 | PR | PR | B | | Yes |
|
|
